Global Updates in Advanced Gastric Cancer from ESMO 2020

home / peer-exchange / global-updates-in-advanced-gastric-cancer-from-esmo-2020

EP. 1: Global Trends in Gastric Cancers

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

EP. 2: Optimal Approach Toward Advanced Gastric Cancers in US

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

EP. 3: Frontline Treatment in Metastatic Gastric Cancer

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

EP. 4: Treatment Landscape in Gastric Cancers Pre-ESMO 2020

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

EP. 5: First-Line I/O Successful in Gastric Adenocarcinoma

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

EP. 6: ESMO 2020: Practice-Changing Data in Esophageal Cancer

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

EP. 7: Applying New Data in the Real-World for GEJ Cancer

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

EP. 8: Predicting Response With Biomarkers in Gastric Cancers

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

EP. 9: Clinical Rationale for Antiangiogenics in Gastric Cancer

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

EP. 10: Toxicity Management in Second Line for Gastric Cancer

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

EP. 11: Looking Toward the Future in Gastroesophageal Cancer

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

EP. 12: Adjuvant Treatment in Gastroesophageal Cancer

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

EP. 13: Maintenance Therapy in Gastric Cancers

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

EP. 14: VEGFR TKIs in Gastroesophageal Cancer

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

EP. 15: Emerging Approaches in HER2+ Gastric Cancers

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

EP. 16: Applying Data to the Real World in Gastric Cancer

By Johanna Bendell, MD, Sarah Cannon Cancer Institute
Daniel V. Catenacci, MD, University of Chicago

October 22nd 2020

Latest Conference Coverage

Navigating the Intersection of Radiation Therapy and Immunotherapy in Endometrial Cancer

As Orthopedic Oncology Evolves, Caring for the Clinician Must Be a Priority

Belumosudil Produces Long-Term Responses Without New Safety Concerns in cGVHD

Prophylactic Itacitinib May Safely Mitigate CRS Following Axi-Cel Administration in Lymphoma

View More Latest Conference Coverage

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512